PGR and medullary thyroid gland carcinoma: In addition, negativity for progesterone receptor (PgR) [3,4], a higher proportion of medullary and atypical medullary carcinomas [5,6], and tumours with a low expression of c-erbB-2 [1,4,6] have been detected.